120 related articles for article (PubMed ID: 12724690)
21. [The effect of nitrogen monoxide and its synthase on the diabetic retinal damage].
Liu QH; Xie P; Ge YB; Yuan XR
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):837-41. PubMed ID: 16191353
[TBL] [Abstract][Full Text] [Related]
22. Diabetic microvascular complications: can patients at risk be identified? A review.
Girach A; Manner D; Porta M
Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
[TBL] [Abstract][Full Text] [Related]
23. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort.
Uthra S; Raman R; Mukesh BN; Rajkumar SA; Kumari R P; Agarwal S; Paul PG; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
Ophthalmic Res; 2007; 39(5):294-9. PubMed ID: 17851271
[TBL] [Abstract][Full Text] [Related]
24. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
25. [Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in patients with type 1 diabetes mellitus].
Zotova EV; Voron'ko OE; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
Mol Biol (Mosk); 2005; 39(2):224-9. PubMed ID: 15856945
[TBL] [Abstract][Full Text] [Related]
26. Management and outcome of sight-threatening diabetic retinopathy in pregnancy.
Chan WC; Lim LT; Quinn MJ; Knox FA; McCance D; Best RM
Eye (Lond); 2004 Aug; 18(8):826-32. PubMed ID: 14976547
[TBL] [Abstract][Full Text] [Related]
27. [The role of anti-pericyte antibodies in the development of diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Klin Oczna; 2005; 107(7-9):541-3. PubMed ID: 16417018
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
[TBL] [Abstract][Full Text] [Related]
29. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
[TBL] [Abstract][Full Text] [Related]
30. [Molecular basis of diabetic retinopathy].
Rusin P; Majsterek I
Postepy Hig Med Dosw (Online); 2007 Dec; 61():786-96. PubMed ID: 18097337
[TBL] [Abstract][Full Text] [Related]
31. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
Wiltshire EJ; Mohsin F; Chan A; Donaghue KC
Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
[TBL] [Abstract][Full Text] [Related]
32. An igf-I gene polymorphism modifies the risk of diabetic retinopathy.
Rietveld I; Ikram MK; Vingerling JR; Hofman A; Pols HA; Lamberts SW; de Jong PT; van Duijn CM; Janssen JA
Diabetes; 2006 Aug; 55(8):2387-91. PubMed ID: 16873705
[TBL] [Abstract][Full Text] [Related]
33. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP.
Maeda S
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S45-7. PubMed ID: 15563979
[TBL] [Abstract][Full Text] [Related]
35. Genetics of diabetic retinopathy.
Uhlmann K; Kovacs P; Boettcher Y; Hammes HP; Paschke R
Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):275-94. PubMed ID: 16868886
[TBL] [Abstract][Full Text] [Related]
36. Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients.
Wobeto VP; Rosim ET; Melo MB; Calliari LE; Sonati Mde F
Diabetes Res Clin Pract; 2007 Sep; 77(3):385-8. PubMed ID: 17275123
[TBL] [Abstract][Full Text] [Related]
37. Length rather than a specific allele of dinucleotide repeat in the 5' upstream region of the aldose reductase gene is associated with diabetic retinopathy.
Fujisawa T; Ikegami H; Kawaguchi Y; Yamato E; Nakagawa Y; Shen GQ; Fukuda M; Ogihara T
Diabet Med; 1999 Dec; 16(12):1044-7. PubMed ID: 10656235
[TBL] [Abstract][Full Text] [Related]
38. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire.
Scanlon PH; Carter SC; Foy C; Husband RF; Abbas J; Bachmann MO
J Med Screen; 2008; 15(3):118-21. PubMed ID: 18927093
[TBL] [Abstract][Full Text] [Related]
39. Genetics of diabetic retinopathy.
Omar AF; Silva PS; Sun JK
Semin Ophthalmol; 2013; 28(5-6):337-46. PubMed ID: 24138043
[TBL] [Abstract][Full Text] [Related]
40. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
